Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.02 USD | +0.16% | +0.65% | +22.61% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.61% | 5.27B | C | ||
-1.29% | 12.64B | B+ | ||
-0.47% | 8.46B | B- | ||
-2.03% | 4.49B | C | ||
-53.56% | 3.11B | D+ | ||
+19.30% | 2.87B | - | - | |
+33.07% | 2.31B | C | ||
-8.42% | 2.23B | B- | ||
-3.55% | 1.89B | D+ | ||
+5.37% | 1.64B | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LNTH Stock
- Ratings Lantheus Holdings, Inc.